How do prescription assistance programs work

So, what could be bad about PAPs? For many years, employers, payers, and pharmacy benefit managers PBMs have been developing benefit designs to incentivize patients and providers to make cost-effective treatment decisions.

Through tiered co-pay and deductible structures, they are attempting to ensure that patients have inancifal skin in the game. Although the true success of these benefit design strategies is controversial, with some evidence that they may have detrimental effects on patient care and outcomes, they are intended to attempt to bend the curve on escalating costs of care. PAPs were primarily introduced to nullify the impact of benefit design on patient financial risk and assure providers that high-cost treatments will not be financially harmful to patients.

The intent is to promote newer, higher-cost treatment options. Given that the cost of PAPs is baked in, it is also a cost-shifting or subsidy strategy, where the expense of high-cost drugs is shared across all commercially insured beneficiaries. On a macro level, the use of PAP programs has the effect of increasing the cost of care for all.

Individuals without insurance can apply to our Patient Assistance Program to receive treatment at no cost; those who qualify can receive their Gilead products free, directly from Gilead. In , more than 40, individuals received treatment at no cost. Approximately half of all individuals taking Gilead HIV medicines in the United States receive them through federal and state programs at substantially discounted prices.

Gilead also offers a copay assistance program to help eligible patients with insurance offset out-of-pocket costs. Gilead recently enhanced these programs to ensure the assistance provided for Truvada is consistent, regardless of whether an individual needs access for prevention or treatment.

In , Gilead launched pioneering programs to provide access to our medicines in low- and middle-income countries. Since that time, we have learned that there is no one-size-fits-all solution to treatment access challenges. To increase education and disease awareness, engage partners strategically and deliver medicines efficiently, we offer:. Just contact Dr. Richard Sagall to obtain permission. It's a choice no one should have to make - pay rent and buy food or get prescriptions filled.

Yet all too often it's a choice Americans, particularly working-age Americans, have to make. Nearly 28 million Americans have no health insurance , and millions more have limited coverage. Many Americans just can't afford healthcare, and, if they can, they don't have the money to buy their medicines. There is help available for many people who can't afford their medicines. These programs, frequently called prescription assistance programs PAPs or patient assistance programs, are designed to help those in need obtain their medicines at no cost or very low cost.

Many, but not all, pharmaceutical companies have PAPs. The manufacturers who have programs do so for various reasons. Some believe that they have a social obligation to help those who can't afford their products. Others believe it's a good marketing tool. As one PAP director once told me, many people who can't afford their medicines now will go on to obtain some type of coverage.

And when they do get this coverage, they will continue using the medication provided by the PAP. Recent statistics show there are more than PAPs in operation in the U.. In the past decade, PAPs have helped more than 36 million people obtain their meds.

All PAPs are designed to help those in need obtain their medicines. Since each pharmaceutical company establishes its own rules and guidelines, all are different.

All have income guidelines, but they vary considerably. Each company selects which drugs are available on their programs and how long a person can receive assistance. The pharmaceutical manufacturers cover the cost of the medicine. Although no two programs are exactly the same, most require an application.

The amount of information required varies. Some programs require detailed medical and financial information, others very little. Patient Advocate Foundation. Patient must be insured by Medicare, Medicaid or military benefits, and insurance must cover the medicine for which patient seeks assistance. Patient Services Incorporated. Funds for Alpha-1 Antitrypsin Deficiency among other respiratory illnesses. Rx Outreach. Provides discounted medicines for eligible patients with asthma and other illnesses.

State Pharmaceutical Assistance Programs. The Assistance Fund. This organization helps with your out-of-pocket costs such as copays, coinsurance, premiums, deductibles and incidental medical expenses.

They compile coupons and prescription assistance information to help patients and families find free or reduced-cost asthma medicines. Extra Help Social Security Administration.